2019 Half Year Media Release
Filed with ASX ·
6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- Half Year Accounts
- Tolsura (SUBA-itraconazole) capsule now launched in the US
- FDA approval of Tolsura (SUBA-itraconazole) capsules
- 2018 AGM CEOs Speech
- 2018 AGM Chairmans Address
Later from Mayne Pharma
- 2019 Half Year Investor Presentation
- 2019 Full Year Results Media Release
- 2019 Full Year Results Investor Presentation
- MYX signs license agreement for novel oral contraceptive
- E4/DRSP contraceptive presented at EU gynecology conference
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma